New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration
Joint Authors
Park, Young Gun
Kang, Seungbum
Roh, Young Jung
Rhu, Hyun Wook
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-02-09
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Age-related macular degeneration (AMD) is the leading cause of visual loss in older population.
Angiogenesis is an important factor associated with the development of CNV due to AMD.
Treatment of CNV with intravitreal anti-VEGF monotherapy is currently the standard of care.
However, not all patients respond to monotherapy, and modified anti-VEGF treatment regimen and combination therapy may target reducing treatment frequency or improving visual outcome.
This paper reviews the many clinical trials that have been performed utilizing several treatment regimens.
While many trials have shown that this variable therapy is justifiable, further study is required to determine correct regimens and dosage.
American Psychological Association (APA)
Park, Young Gun& Rhu, Hyun Wook& Kang, Seungbum& Roh, Young Jung. 2012. New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration. Journal of Ophthalmology،Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-487126
Modern Language Association (MLA)
Park, Young Gun…[et al.]. New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration. Journal of Ophthalmology No. 2012 (2012), pp.1-7.
https://search.emarefa.net/detail/BIM-487126
American Medical Association (AMA)
Park, Young Gun& Rhu, Hyun Wook& Kang, Seungbum& Roh, Young Jung. New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration. Journal of Ophthalmology. 2012. Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-487126
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-487126
